Mark Deneau
No Rating Available
(Learn About Our Rating System)

Mark Deneau, MD, MS, FAAP

Languages spoken: English

Clinical Locations

Eccles Primary Children's Outpatient Services

Salt Lake City
801-213-3599

Primary Children's Hospital Outpatient Services at Riverton

Riverton
801-212-3359

  • Dr. Deneau is active in all aspects of pediatric gastroenterology and endoscopy. His main areas of clinical expertise are: inflammatory bowel disease (IBD; ulcerative colitis and Crohn disease), neonates and infants with liver disease and short bowel syndrome, and the inpatient care of very ill and hospitalized patients. Dr. Deneau is a member of the inflammatory bowel disease clinic. He has IBD himself, and has been down the same road as many of his patients, with a first-hand knowledge of what it is like to live with this problem and have surgery. He is not shy about sharing his personal experiences with his patients when helpful. He truly takes this disease to heart, and tries to make the lives of his IBD patients better. Dr. Deneau created and directs a unique neonatal intensive care unit (NICU) gastroenterology clinic. Ill infants in the NICU, who often require months-long hospitalizations for complex bowel and liver diseases, are now seen by only one gastroenterologist for their entire stay in the hospital and after going home. This program helps facilitate better communication, gives families one familiar face who knows their child well, and most importantly, tries to get patients home faster. Dr. Deneau takes a conservative and thoughtful approach to patient care, and tries to avoid invasive procedures and excessive testing when possible. His goal is to make gastrointestinal diseases and symptoms as small a part of his patient's day-to-day lives as possible. Dr. Deneau is active in teaching and training medical students, pediatric residents, and fellows. He has won multiple teaching awards and brings this talent for communication to his patient care. He excels at making sure his patients and families understand their diagnoses, procedures and medications. Dr. Deneau is active in clinical research of liver disease in patients with inflammatory bowel disease, especially primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). He is active in multiple quality improvement projects throughout the hospital to improve patient safety and lower costs of care for gastrointestinal diseases.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Gastroenterology)

  • Dr. Deneau is active in all aspects of pediatric gastroenterology and endoscopy. His main areas of clinical expertise are: inflammatory bowel disease (IBD; ulcerative colitis and Crohn disease), neonates and infants with liver disease and short bowel syndrome, and the inpatient care of very ill and hospitalized patients. Dr. Deneau is a member of the inflammatory bowel disease clinic. He has IBD himself, and has been down the same road as many of his patients, with a first-hand knowledge of what it is like to live with this problem and have surgery. He is not shy about sharing his personal experiences with his patients when helpful. He truly takes this disease to heart, and tries to make the lives of his IBD patients better. Dr. Deneau created and directs a unique neonatal intensive care unit (NICU) gastroenterology clinic. Ill infants in the NICU, who often require months-long hospitalizations for complex bowel and liver diseases, are now seen by only one gastroenterologist for their entire stay in the hospital and after going home. This program helps facilitate better communication, gives families one familiar face who knows their child well, and most importantly, tries to get patients home faster. Dr. Deneau takes a conservative and thoughtful approach to patient care, and tries to avoid invasive procedures and excessive testing when possible. His goal is to make gastrointestinal diseases and symptoms as small a part of his patient's day-to-day lives as possible. Dr. Deneau is active in teaching and training medical students, pediatric residents, and fellows. He has won multiple teaching awards and brings this talent for communication to his patient care. He excels at making sure his patients and families understand their diagnoses, procedures and medications. Dr. Deneau is active in clinical research of liver disease in patients with inflammatory bowel disease, especially primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). He is active in multiple quality improvement projects throughout the hospital to improve patient safety and lower costs of care for gastrointestinal diseases.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Gastroenterology, Hepatology, & Nutrition
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Gastroenterology)

    Education history

    Graduate Training Clinical Investigation - University of Utah M.S.
    Pediatric Gastroenterology, Hepatology and Nutrition - University of Utah Fellow
    Residency General Pediatrics - University of Utah Resident
    Medicine - Wayne State University M.D.
    Undergraduate Electrical Engineering - Purdue University B.S.

    Selected Publications

    Journal Article

    1. Ricciuto A, Liu K, El-Matary W, Amin M, Amir AZ, Aumar M, Auth M, Di Guglielmo MD, Druve Tavares Fagundes E, Rodrigues Ferreira A, Furuya KN, Gupta N, Guthery S, Horslen SP, Jensen K, Kamath BM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Mack C, Martinez M, Montano-Loza A, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Schwarz KB, Shah U, Shteyer E, Soufi N, Stevens JP, Taylor A, Tessier ME, Valentino P, Woynarowski M, Deneau M, Pediatric PSC Consortium (2024). Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium. Aliment Pharmacol Ther. (Read full article)
    2. Bowlus CL, Arriv L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN (2023). Reply: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology, 77(6), E176-E177. (Read full article)
    3. Kastenberg ZJ, Deneau MR, OBrien EA, Huynh K, Book LS, Srivastava R, Jensen MK, Jaramillo CM, Guthery SL (2023). Fractionated Bilirubin Among 252 892 Utah Newborns with and Without Biliary Atresia: A 15-year Historical Birth Cohort Study. J Pediatr, 257, 113339. (Read full article)
    4. Bowlus CL, Arriv L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN (2022). AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology, 77(2), 659-702. (Read full article)
    5. Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI (2022). Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America. J Pediatr Gastroenterol Nutr, 75(1), 64-69. (Read full article)
    6. Montano-Loza AJ, Ronca V, Ebadi M, Hansen BE, Hirschfield G, Elwir S, Alsaed M, Milkiewicz P, Janik MK, Marschall HU, Burza MA, Efe C, Calkan AR, Harputluoglu M, Kabaam G, Terrabuio D, de Quadros Onofrio F, Selzner N, Bonder A, Pars A, Llovet L, Akyldz M, Arikan C, Manns MP, Taubert R, Weber AL, Schiano TD, Haydel B, Czubkowski P, Socha P, Odak N, Akamatsu N, Tanaka A, Levy C, Martin EF, Goel A, Sedki M, Jankowska I, Ikegami T, Rodriguez M, Sterneck M, Weiler-Normann C, Schramm C, Donato MF, Lohse A, Andrade RJ, Patwardhan VR, van Hoek B, Biewenga M, Kremer AE, Ueda Y, Deneau M, Pedersen M, Mayo MJ, Floreani A, Burra P, Secchi MF, Beretta-Piccoli BT, Sciveres M, Maggiore G, Jafri SM, Debray D, Girard M, Lacaille F, Lytvyak E, Mason AL, Heneghan M, Oo YH, International Autoimmune Hepatitis Group IAIHG (2022). Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation. J Hepatol. (Read full article)
    7. Martinez M, Perito ER, Valentino P, Mack CL, Aumar M, Broderick A, Draijer LG, Fagundes EDT, Furuya KN, Gupta N, Horslen S, Jonas MM, Kamath BM, Kerkar N, Kim KM, Kolho KL, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Miloh T, Mogul D, Mohammed S, Ovchinsky N, Rao G, Ricciuto A, Rodrigues Ferreira A, Schwarz KB, Smolka V, Tanaka A, Tessier MEM, Venkat VL, Vitola BE, Woynarowski M, Zerofsky M, Deneau MR (2021). Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study. Hepatology, 74(4), 2047-2057. (Read full article)
    8. Ponsioen CY, Assis DN, Boberg KM, Bowlus CL, Deneau M, Thorburn D, Aabakken L, Frkkil M, Petersen B, Rupp C, Hbscher SG, Primary Sclerosing Cholangitis Study Group (2021). Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology, 161, 1764-1775.e5. (Read full article)
    9. El-Matary W, Guthery SL, Amir AZ, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Hochberg JT, Horslen S, Kerkar N, Koot BGP, Laborda TJ, Loomes KM, Mack C, Martinez M, Miethke A, Miloh T, Mogul D, Mohammed S, Moroz S, Ovchinsky N, Perito ER, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Soufi N, Valentino PL, Zizzo A, Deneau MR (2020). Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol, 19(5), 1067-1070.e2. (Read full article)
    10. Deneau MR, Mack C, Perito ER, Ricciuto A, Valentino PL, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, Tavares Fagundes ED, El-Matary W, Ferrari F, Furuya KN, Gupta N, Hochberg JT, Homan M, Horslen S, Iorio R, Jensen MK, Jonas MM, Kamath BM, Kerkar N, Kim KM, Kolho KL, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mogul D, Mohammad S, Mohan P, Moroz S, Ovchinsky N, Palle S, Papadopoulou A, Rao G, Rodrigues Ferreira A, Sathya P, Schwarz KB, Shah U, Shteyer E, Singh R, Smolka V, Soufi N, Tanaka A, Varier R, Vitola B, Woynarowski M, Zerofsky M, Zizzo A, Guthery SL (2020). The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children. Hepatology, 73(3), 1074-1087. (Read full article)
    11. Deneau MR, Mack C, Mogul D, Perito ER, Valentino PL, Amir AZ, DiGuglielmo M, Draijer LG, El-Matary W, Furuya KN, Gupta N, Hochberg JT, Horslen S, Jensen MK, Jonas MM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mohammad S, Ovchinsky N, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Vitola B, Zizzo A, Guthery SL (2020). Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis. Hepatology, 73(3), 1061-1073. (Read full article)
    12. Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD (2020). Natural History of  Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis, 27(3), 295-302. (Read full article)
    13. Taylor MA, West WB, Guthery SL, Deneau M, Short SS (2020). Ketorolac after colectomy for ulcerative colitis in children: An analysis of opioid utilization and postoperative complications. J Pediatr Surg, 55(11), 2393-2396. (Read full article)
    14. Laborda TJ, Ricciuto A, Aumar M, Carman N, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Koot BGP, Loomes KM, Lytvyak E, Martinez M, Miloh T, Montano-Loza AJ, Perito ER, Sathya P, Shah U, Shteyer E, Singh R, Taylor A, Valentino PL, Vitola B, Zerofsky M, Zizzo A, Deneau MR (2020). Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium. J Pediatr Gastroenterol Nutr, 71(4), 459-464. (Read full article)
    15. Deneau MR, Valentino PL, Mack C, Alqoaer K, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, El-Matary W, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Kim KM, Kolho KL, Koot B, Iorio R, Martinez M, Miloh T, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Woynarowski M, Guthery S (2019). Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children. J Pediatr Gastroenterol Nutr, 70(1), e12-e17. (Read full article)
    16. Chandrakumar A, Loeppky R, Deneau M, El-Matary W (2019). Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels. J Pediatr, 215, 144-151.e3. (Read full article)
    17. Deneau M, Perito E, Ricciuto A, Gupta N, Kamath BM, Palle S, Vitola B, Smolka V, Ferrari F, Amir AZ, Miloh T, Papadopoulou A, Mohan P, Mack C, Kolho KL, Iorio R, El-Matary W, Venkat V, Chan A, Saubermann L, Valentino PL, Shah U, Miethke A, Lin H, Jensen MK (2019). Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course. J Pediatr, 209, 92-96.e1. (Read full article)
    18. Johnson E, Ermarth A, Deneau M (2019). A Novel Care Model for Neonatal Intestinal Failure Patients Is Associated With Cost Savings and Improved Outcomes. Gastroenterology Res, 12(2), 93-95. (Read full article)
    19. Laborda TJ, Jensen MK, Kavan M, Deneau M (2018). Treatment of primary sclerosing cholangitis in children. World J Hepatol, 11(1), 19-36. (Read full article)
    20. Deneau MR, Mack C, Abdou R, Amin M, Amir A, Auth M, Bazerbachi F, Marie Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Mo Kim K, Kolho KL, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Valentino PL, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Miloh T (2018). Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis. Hepatol Commun, 2(11), 1369-1378. (Read full article)
    21. Soufi N, Bazerbachi F, Deneau M (2018). Post-Transplant Disease Recurrence in Pediatric PSC. Curr Gastroenterol Rep, 20(9), 44. (Read full article)
    22. Sandweiss DR, Allen L, Deneau M, Harnsberger J, Pasmann A, Smout R, Mundorff M, Dudley N (2018). Implementing a Standardized Constipation-Management Pathway to Reduce Resource Utilization. Acad Pediatr, 18(8), 957-964. (Read full article)
    23. Deneau M, Mutyala R, Sandweiss D, Harnsberger J, Varier R, Pohl JF, Allen L, Thackeray C, Zobell S, Maloney C (2017). Reducing hospital admissions of healthy children with functional constipation: a quality initiative. BMJ Open Qual, 6(2), e000116. (Read full article)
    24. Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Youssef M, Ferrari F, Furuya KN, Gottrand M, Gottrand F, Gupta N, Homan M, Kamath BM, Kim KM, Kolho KL, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Jensen MK (2017). The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration. Hepatology, 66(2), 518-527. (Read full article)
    25. Jaramillo C, Valentino P, Deneau M (7/1/2017). Update on Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlap Syndrome in Childhood. Curr Hepatol Rep, 2017(3).
    26. Saubermann LJ, Deneau M, Falcone RA, Murray KF, Ali S, Kohli R, Ekong UD, Valentino PL, Grossman AB, Rand EB, Jonas MM, Saeed SA, Kamath BM (2016). Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees. J Pediatr Gastroenterol Nutr, 64(4), 639-652. (Read full article)
    27. Lascurain L, Jensen MK, Guthery SL, Holmen J, Deneau M (2015). Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis. Inflamm Bowel Dis, 22(1), 146-50. (Read full article)
    28. Mhanni AA, Kozenko M, Hartley JN, Deneau M, El-Matary W, Rockman-Greenberg C (2015). Successful therapy for protein-losing enteropathy caused by chronic neuronopathic Gaucher disease. Mol Genet Metab Rep, 6, 13-5. (Read full article)
    29. Jimenez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez F (2015). Incidence and Characteristics of Autoimmune Hepatitis. Pediatrics, 136(5), 1237-1248.
    30. Deneau M, Book LS, Guthery SL, Jensen MK (2014). Outcome after discontinuation of immunosuppression in children with autoimmune hepatitis: a population-based study. J Pediatr, 164(4), 714-719.e2. (Read full article)
    31. Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL (2013). Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology, 58(4), 1392-400. (Read full article)

    Case Report

    1. Jaramillo C, Ermarth AK, Putnam AR, Deneau M (2019). Neonatal cholestasis and hepatosplenomegaly caused by congenital dyserythropoietic anemia type 1: A case report. World J Hepatol, 11(5), 477-482. (Read full article)

    Letter

    1. Forman LM, Sapisochin G, Assis DN, Arriv L, Bergquist A, Bowlus CL, Deneau M, Ilyas SI, Lunsford KE, Martinez M, Shroff R, Tabibian JH (2023). Reply: Living donor liver transplantation for people with PSC. [Letter to the editor]. Hepatology, 77(5), E97-E98. (Read full article)
    2. Deneau M (2021). REPLY. [Letter to the editor]. Hepatology, 74(3), 1717. (Read full article)

    Abstract

    1. Deneau M, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2018). Clinical Outcomes of Oral Vancomycin Therapy in Children in the Pediatric PSC Consortium [Abstract]. Hepatology, 68(S1).
    2. Deneau M, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2018). Variability in Diagnostic and Therapeutic Practices Between Centers in the Pediatric PSC Consortium [Abstract]. Hepatology, 68(S1).
    3. Johnson E, Deneau M, Ermarth A (10/1/2018). A NOVEL CARE MODEL FOR INTESTINAL FAILURE PATIENTS IN THE NICU: EARLIER DISCHARGE, FEWER READMISSIONS, AND MULTIMILLION DOLLAR COST SAVINGS [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 66(S1).
    4. Deneau M, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2018). MELD and Liver Transplantation in Pediatric Primary Sclerosing Cholangitis, Data From the Pediatric PSC Consortium [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 66(S1).
    5. Jaramillo C, Guthery S, Deneau M (11/1/2017). Inflammatory Bowel Disease in Hispanic Children: A Population-Based Study [Abstract]. Jounral of Pediatric Gastroenterology and Nutrition, 65(S2), S39-S40.
    6. McClain A, Anderson C, Leukler J, Deneau M (11/1/2017). Early vs. Late Initiation of Parenteral Nutrition in a Pediatric ICU: A Quality Improvement Initiative [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 65(S2), S79-S80.
    7. Deneau M, Guthery S (11/1/2017). Cancer is More Common in Children with Inflammatory Bowel Disease Regardless of Immunosuppression Regimen [Abstract]. Jounral of Pediatric Gastroenterology and Nutrition, 65(S2), S232-S233.
    8. Deneau M, Mutyala K, Book L, Ermarth A, Guthery S, Harnsberger J, Jaramillo C, Jackson WD, Jensen MK, Kavan M, McClain A, OGorman M, Patel R, Pohl JF, Robson J, Sandweiss D, Sutton T, Varier R, Maloney C (11/1/2017). How We Stopped Admitting Children for Bowel Cleanouts [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 65(S2), S144-S145.
    9. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (11/1/2017). Improvement in GGT Predicts Event-Free Survival in Primary Sclerosing Cholangitis Regardless of Ursodeoxycholic Acid Treatment: Data from the Pediatric PSC Consortium [Abstract]. Jounral of Pediatric Gastroenterology and Nutrition, 65(S2), S105-106.
    10. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (11/1/2017). Validating the Mayo Model of Primary Sclerosing Cholangitis Outcomes in Children: Data from the Pediatric PSC Consortium [Abstract]. Jounral of Pediatric Gastroenterology and Nutrition, 65(S2), S162.
    11. Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (11/1/2017). Primary Sclerosing Cholangitis with and without Association Inflammatory Bowel Disease: Data from the Pediatric PSC Consortium [Abstract]. Jounral of Pediatric Gastroenterology and Nutrition, 65(S2), S48-S49.
    12. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2017). Validating the Mayo Model of Primary Sclerosing Cholangitis Outcomes in Children: Data from the Pediatric PSC Consortium [Abstract]. Hepatology, 66(S1), 649-650A.
    13. Deneau M, Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J (10/1/2017). Improvement in GGT Predicts Event-Free Survival in Primary Sclerosing Cholangitis Regardless of Treatment with Ursodeoxycholic Acid: Data from the Pediatric PSC Consortium [Abstract]. Hepatology, 66(S1), 58A.
    14. Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). A comparison of primary sclerosing cholangitis with and without associated inflammatory bowel disease: data from the pediatric PSC consortium [Abstract]. Gastroenterology, 152(5 (Supplement 1)), S1057.
    15. Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Bazerbacki F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). A comparison of primary sclerosing cholangitis with and without associated inflammatory bowel disease: data from the pediatric PSC consortium [Abstract]. Journal of Pediatric Gastroenterology and Nutrition (JPGN), 64(Supplement 1), S576.
    16. Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). Recurrence of primary sclerosing cholangitis after liver transplantation in children: data from the Pediatric PSC Consortium [Abstract]. Journal of Hepatology, 66(Supplement 1), S76.
    17. Bazerbachi F, Ricciuto A, Kamath B, Abdou R, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). Recurrence of primary sclerosing cholangitis after liver transplantation in children: data from the Pediatric PSC Consortium [Abstract]. Gastroenterology, 152(5 (supplement 1)), S1062-1064.
    18. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). Laboratory predictors of longterm prognosis in primary sclerosing cholangitis: data from the pediatric PSC consortium [Abstract]. Hepatology, 63(1), 350A.
    19. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). Ursodeoxycholic acid treatment does not improve liver outcomes in pediatric PSC: a multicenter, international collaboration [Abstract]. Hepatology, 63(1), 349A.
    20. Ricciuto A, Kamath B, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK, Deneau M (October 2016). Primary sclerosing cholangitis and autoimmune sclerosing cholangitis are associated with similar outcomes: data from the pediatric PSC consortium [Abstract]. Hepatology, 63(1), 352A.
    21. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK (October 2016). The Natural History of Primary Sclerosing Cholangitis in 500 Children: A multicenter, international collaboration [Abstract]. Hepatology, 63(1), 72A.
    22. Mutyala R, Jaramillo C, Ermarth A, Weinheimer C, Jackson WD, Coombs S, Deneau M (10/6/2016). Early discharge of intestinal failure patients from the NICU: a pilot quality improvement initiative [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 63(S), S401.
    23. Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M Kyle Jensen, Deneau M (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration [Abstract]. Hepatology, 62(S1), 1038A.
    24. Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M Kyle Jensen, Deneau M (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), 184.
    25. Ramakrishna Mutyala, Deneau M, Linda Book, Robin Kim, Ronald Day, M Kyle Jensen (2015). Frequency and Impact of Severe Hepatopulmonary Syndrome on Liver Transplantation in Children [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), S187.
    26. Lascurain L, Deneau M (2015). Inflammatory bowel disease spares the poor but autoimmune hepatitis does not: socioeconomic factors in immune-mediated disease in Utah [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), S174.
    27. Ermarth A, Deneau M (2015). Clinical characteristics of very early onset inflammatory bowel disease: a population-based cohort [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 61(S2), S22.
    28. Mhanni A, Rockman-Greenberg C, Deneau M, Hartley J (10/1/2014). Mesenteric lymphadenopathy and protein-losing enteropathy in Gaucher disease type 3 despite combined enzyme replacement and substrate reduction therapy [Abstract]. Clinical Biochemistry, 47(15), 139.
    29. Deneau M, Book L, Guthery SL, Jensen MK (2013). Sustained immunosuppression-free remission in pediatric autoimmune hepatitis: a population-based study [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 57(Suppl 1).
    30. Lascurain L, Deneau M, Guthery SL, Jensen MK (2013). Inflammatory bowel disease activity and distribution in children with and without primary sclerosing cholangitis [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 57(Suppl 1).
    31. Deneau M, Book L, Guthery SL, Jensen MK (2013). Sustained immunosuppression-free remission in pediatric autoimmune hepatitis: a population-based study [Abstract]. Hepatology, 58(S1).
    32. Deneau M, Jensen MK, Holmen J, Williams MS, Bleyl S, Guthery S (2012). Pediatric Primary Sclerosing Cholangitis and Inflammatory Bowel Disease in Utah: A Population-Based Study [Abstract]. Journal of Pediatric Gastroenterology and Nutrition, 55(Suppl 1).

    Video/Film/CD/Web/Podcast

    1. Deneau MR (2021). The SCOPE Index online [Web].